Management of Axilla in 2015 in Indian Scenario
Identifieur interne : 000F16 ( Pmc/Corpus ); précédent : 000F15; suivant : 000F17Management of Axilla in 2015 in Indian Scenario
Auteurs : D. K. Vijaykumar ; M. ArunlalSource :
- Indian Journal of Surgical Oncology [ 0975-7651 ] ; 2015.
Abstract
Sentinel lymph node biopsy is now increasingly being considered the favored method to treat low volume axilla. Most often this is followed by adjuvant radiation directed at axilla. In India however, sentinel node itself is still not widely practiced. The radiotherapy facilities are also not uniform, with cobalt units still being used in many centers. The long-term complications related to radiation are not assessed well. In fact there are also questions whether the evidence from early screen detected cancers in western population can be blindly followed in our population with a possibly different tumor biology and presentation as locally advanced being the norm. However, it is possible that we will see lesser axillary surgery in the minimal axillary disease group, in the not so distant future. We will look at the emerging evidence with an open mind and try to look at how this is applicable to our scenario.
Url:
DOI: 10.1007/s13193-015-0466-0
PubMed: 27065670
PubMed Central: 4809845
Links to Exploration step
PMC:4809845Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Management of Axilla in 2015 in Indian Scenario</title><author><name sortKey="Vijaykumar, D K" sort="Vijaykumar, D K" uniqKey="Vijaykumar D" first="D. K." last="Vijaykumar">D. K. Vijaykumar</name><affiliation><nlm:aff id="Aff1">Department of Gynecologic Oncology, Amrita Institute of Medical Sciences and Research Centre, Amrita Vishwa Vidyapeetham, Kochi, Kerala India</nlm:aff></affiliation></author><author><name sortKey="Arunlal, M" sort="Arunlal, M" uniqKey="Arunlal M" first="M." last="Arunlal">M. Arunlal</name><affiliation><nlm:aff id="Aff2">Aster Medcity, Kochi, Kerala India</nlm:aff></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PMC</idno><idno type="pmid">27065670</idno><idno type="pmc">4809845</idno><idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4809845</idno><idno type="RBID">PMC:4809845</idno><idno type="doi">10.1007/s13193-015-0466-0</idno><date when="2015">2015</date><idno type="wicri:Area/Pmc/Corpus">000F16</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000F16</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Management of Axilla in 2015 in Indian Scenario</title><author><name sortKey="Vijaykumar, D K" sort="Vijaykumar, D K" uniqKey="Vijaykumar D" first="D. K." last="Vijaykumar">D. K. Vijaykumar</name><affiliation><nlm:aff id="Aff1">Department of Gynecologic Oncology, Amrita Institute of Medical Sciences and Research Centre, Amrita Vishwa Vidyapeetham, Kochi, Kerala India</nlm:aff></affiliation></author><author><name sortKey="Arunlal, M" sort="Arunlal, M" uniqKey="Arunlal M" first="M." last="Arunlal">M. Arunlal</name><affiliation><nlm:aff id="Aff2">Aster Medcity, Kochi, Kerala India</nlm:aff></affiliation></author></analytic><series><title level="j">Indian Journal of Surgical Oncology</title><idno type="ISSN">0975-7651</idno><idno type="eISSN">0976-6952</idno><imprint><date when="2015">2015</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p>Sentinel lymph node biopsy is now increasingly being considered the favored method to treat low volume axilla. Most often this is followed by adjuvant radiation directed at axilla. In India however, sentinel node itself is still not widely practiced. The radiotherapy facilities are also not uniform, with cobalt units still being used in many centers. The long-term complications related to radiation are not assessed well. In fact there are also questions whether the evidence from early screen detected cancers in western population can be blindly followed in our population with a possibly different tumor biology and presentation as locally advanced being the norm. However, it is possible that we will see lesser axillary surgery in the minimal axillary disease group, in the not so distant future. We will look at the emerging evidence with an open mind and try to look at how this is applicable to our scenario.</p></div></front></TEI><pmc article-type="review-article"><pmc-comment>The publisher of this article does not allow downloading of the full text in XML form.</pmc-comment>
<front><journal-meta><journal-id journal-id-type="nlm-ta">Indian J Surg Oncol</journal-id><journal-id journal-id-type="iso-abbrev">Indian J Surg Oncol</journal-id><journal-title-group><journal-title>Indian Journal of Surgical Oncology</journal-title></journal-title-group><issn pub-type="ppub">0975-7651</issn><issn pub-type="epub">0976-6952</issn><publisher><publisher-name>Springer India</publisher-name><publisher-loc>New Delhi</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">27065670</article-id><article-id pub-id-type="pmc">4809845</article-id><article-id pub-id-type="publisher-id">466</article-id><article-id pub-id-type="doi">10.1007/s13193-015-0466-0</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review Article</subject></subj-group></article-categories><title-group><article-title>Management of Axilla in 2015 in Indian Scenario</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Vijaykumar</surname><given-names>D. K.</given-names></name><address><email>dkvijaykumar@aims.amrita.edu</email></address><xref ref-type="aff" rid="Aff1"></xref></contrib><contrib contrib-type="author"><name><surname>Arunlal</surname><given-names>M.</given-names></name><xref ref-type="aff" rid="Aff2"></xref></contrib><aff id="Aff1"><label></label>Department of Gynecologic Oncology, Amrita Institute of Medical Sciences and Research Centre, Amrita Vishwa Vidyapeetham, Kochi, Kerala India</aff><aff id="Aff2"><label></label>Aster Medcity, Kochi, Kerala India</aff></contrib-group><pub-date pub-type="epub"><day>30</day><month>10</month><year>2015</year></pub-date><pub-date pub-type="ppub"><month>12</month><year>2015</year></pub-date><volume>6</volume><issue>4</issue><fpage>435</fpage><lpage>439</lpage><history><date date-type="received"><day>20</day><month>8</month><year>2015</year></date><date date-type="accepted"><day>1</day><month>9</month><year>2015</year></date></history><permissions><copyright-statement>© Indian Association of Surgical Oncology 2015</copyright-statement></permissions><abstract id="Abs1"><p>Sentinel lymph node biopsy is now increasingly being considered the favored method to treat low volume axilla. Most often this is followed by adjuvant radiation directed at axilla. In India however, sentinel node itself is still not widely practiced. The radiotherapy facilities are also not uniform, with cobalt units still being used in many centers. The long-term complications related to radiation are not assessed well. In fact there are also questions whether the evidence from early screen detected cancers in western population can be blindly followed in our population with a possibly different tumor biology and presentation as locally advanced being the norm. However, it is possible that we will see lesser axillary surgery in the minimal axillary disease group, in the not so distant future. We will look at the emerging evidence with an open mind and try to look at how this is applicable to our scenario.</p></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Breast cancer</kwd><kwd>Axillary dissection</kwd><kwd>Sentinel node</kwd><kwd>axillary radiation</kwd><kwd>Regional nodal irradiation</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>© Indian Association of Surgical Oncology 2015</meta-value></custom-meta></custom-meta-group></article-meta></front></pmc></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Pmc/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000F16 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd -nk 000F16 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= Pmc
|étape= Corpus
|type= RBID
|clé= PMC:4809845
|texte= Management of Axilla in 2015 in Indian Scenario
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/RBID.i -Sk "pubmed:27065670" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |